Dashboard
Manage Tickers

NRIXNurix Therapeutics, Inc.

Nasdaq nurixtx.com


$ 21.34 $ 0.33 (1.57 %)    

Friday, 21-Jun-2024 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 480.84 $ -1.29 (-0.27 %)
DIA $ 391.56 $ -0.73 (-0.19 %)
SPY $ 544.47 $ -0.73 (-0.13 %)
TLT $ 93.96 $ 0.00 (0 %)
GLD $ 214.79 $ -3.38 (-1.55 %)
$ 21.3
$ 21.06
$ 0.00 x 0
$ 0.00 x 0
$ 20.75 - $ 21.88
$ 4.22 - $ 21.99
2,192,470
na
1.17B
$ 1.13
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-10-2024 02-29-2024 10-Q
2 02-15-2024 11-30-2023 10-K
3 10-12-2023 08-31-2023 10-Q
4 07-13-2023 05-31-2023 10-Q
5 04-13-2023 02-28-2023 10-Q
6 02-09-2023 11-30-2022 10-K
7 10-06-2022 08-31-2022 10-Q
8 07-07-2022 05-31-2022 10-Q
9 04-08-2022 02-28-2022 10-Q
10 01-28-2022 11-30-2021 10-K
11 10-14-2021 08-31-2021 10-Q
12 07-13-2021 05-31-2021 10-Q
13 04-13-2021 02-28-2021 10-Q
14 02-16-2021 11-30-2020 10-K
15 10-14-2020 08-31-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

nvidia-to-rally-around-53-here-are-10-top-analyst-forecasts-for-tuesday
Nvidia To Rally Around 53%? Here Are 10 To...
06/18/2024 13:44:27

hc-wainwright--co-maintains-buy-on-nurix-therapeutics-raises-price-target-to-26
HC Wainwright & Co. Maintains Buy on Nurix...
06/18/2024 10:10:20

HC Wainwright & Co. analyst Robert Burns maintains Nurix Therapeutics (NASDAQ:NRIX) with a Buy and raises the price targ...

whats-going-on-with-small-cap-cancer-focused-nurix-therapeutics-on-monday
What's Going On With Small-Cap Cancer Focu...
06/17/2024 15:47:08

Nurix Therapeutics presented updated clinical data for NX-5948, an orally bioavailable BTK degrader, at the EHA Congress. NX-59...

jp-morgan-maintains-overweight-on-nurix-therapeutics-raises-price-target-to-31
JP Morgan Maintains Overweight on Nurix Th...
06/17/2024 14:09:15

JP Morgan analyst Eric Joseph maintains Nurix Therapeutics (NASDAQ:NRIX) with a Overweight and raises the price target from ...

why-nurix-therapeutics-shares-are-trading-higher-by-around-12-here-are-20-stocks-moving-premarket
Why Nurix Therapeutics Shares Are Trading ...
06/17/2024 12:43:16

nurix-therapeutics-shares-are-trading-higher-after-the-company-announced-results-from-its-ongoing-clinical-trial-of-nx-5948-in-patients-with-relapsed-refractory-chronic-lymphocytic-leukemia
Nurix Therapeutics shares are trading high...
06/17/2024 11:32:53

needham-reiterates-buy-on-nurix-therapeutics-maintains-31-price-target
Needham Reiterates Buy on Nurix Therapeuti...
06/17/2024 09:49:28

Needham analyst Gil Blum reiterates Nurix Therapeutics (NASDAQ:NRIX) with a Buy and maintains $31 price target.

reported-sunday-nurix-therapeutics-confirms-efficacy-of-nx-5948-in-relapsed-cll-with-692-objective-response-presented-at-eha2024
Reported Sunday, Nurix Therapeutics Confir...
06/17/2024 07:32:56

Objective response rate of 69.2% observed in heavily pretreated patient population including patients with BTK inhibitor resi...

nurix-therapeutics-inc-files-for-mixed-shelf-size-not-disclosed
Nurix Therapeutics Inc Files For Mixed She...
06/11/2024 20:09:58

-SEC Filing

peeling-back-the-layers-exploring-nurix-therapeutics-through-analyst-insights
Peeling Back The Layers: Exploring Nurix T...
06/05/2024 16:00:20

piper-sandler-maintains-overweight-on-nurix-therapeutics-maintains-35-price-target
Piper Sandler Maintains Overweight on Nuri...
06/05/2024 14:05:24

Piper Sandler analyst Joseph Catanzaro maintains Nurix Therapeutics (NASDAQ:NRIX) with a Overweight and maintains $35 price ...

nurix-therapeutics-says-david-lacey-steps-down-from-chair-role-and-will-remain-board-member-and-retain-committee-leadership-roles-current-board-member-julia-gregory-elected-new-board-chair
Nurix Therapeutics Says David Lacey Steps ...
05/20/2024 20:01:41

stifel-maintains-buy-on-nurix-therapeutics-maintains-27-price-target
Stifel Maintains Buy on Nurix Therapeutics...
05/15/2024 11:50:06

Stifel analyst Stephen Willey maintains Nurix Therapeutics (NASDAQ:NRIX) with a Buy and maintains $27 price target.

needham-reiterates-buy-on-nurix-therapeutics-maintains-31-price-target
Needham Reiterates Buy on Nurix Therapeuti...
05/14/2024 16:04:48

Needham analyst Gil Blum reiterates Nurix Therapeutics (NASDAQ:NRIX) with a Buy and maintains $31 price target.

nurix-therapeutics-upcoming-oral-presentation-of-data-from-ongoing-clinical-trial-of-nx-5948-a-selective-btk-degrader-at-eha2024-june-13---16-2024-in-madrid-spain
Nurix Therapeutics Upcoming Oral Presentat...
05/14/2024 14:04:19

Overall response rate of 70% observed in 10 evaluable heavily pretreated CLL patients Data showcase deepening clinical response...

key-takeaways-from-nurix-therapeutics-analyst-ratings
Key Takeaways From Nurix Therapeutics Anal...
05/14/2024 12:01:32

stephens--co-initiates-coverage-on-nurix-therapeutics-with-overweight-rating-announces-price-target-of-20
Stephens & Co. Initiates Coverage On Nurix...
05/14/2024 10:03:15

Stephens & Co. analyst Sudan Loganathan initiates coverage on Nurix Therapeutics (NASDAQ:NRIX) with a Overweight rating ...

why-jpmorgan-shares-are-trading-lower-by-around-5-here-are-other-stocks-moving-in-fridays-mid-day-session
Why JPMorgan Shares Are Trading Lower By A...
04/12/2024 18:47:23

Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings.

applied-digital-reports-downbeat-results-joins-nurix-therapeutics-and-other-big-stocks-moving-lower-in-fridays-pre-market-session
Applied Digital Reports Downbeat Results, ...
04/12/2024 12:04:19

U.S. stock futures were lower this morning, with the Dow futures falling over 50 points on Friday.

why-nextplat-shares-are-trading-higher-by-around-30-here-are-20-stocks-moving-premarket
Why NextPlat Shares Are Trading Higher By ...
04/12/2024 09:32:49

Shares of NextPlat Corp (NASDAQ: NXPL) rose sharply in today’s pre-market trading after the company reported consolidated 2023...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)